Vanguard Group
OYST

Vanguard Group’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Vanguard Group’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,500
Closed -$151K – 4657
2022
Q4 		$151K Sell
13,500
-413,595
-97% -$4.01M ﹤0.01% 4346
2022
Q3 		$2.4M Sell
427,095
-239,620
-36% -$1.5M ﹤0.01% 3678
2022
Q2 		$2.89M Sell
666,715
-948
-0.1% -$5.39K ﹤0.01% 3645
2022
Q1 		$7.77M Buy
667,663
+5,490
+0.8% +$65.4K ﹤0.01% 3281
2021
Q4 		$12.1M Buy
662,173
+35,906
+6% +$456K ﹤0.01% 3117
2021
Q3 		$7.42M Buy
626,267
+4,471
+0.7% +$65.1K ﹤0.01% 3415
2021
Q2 		$10.7M Buy
621,796
+60,886
+11% +$1.16M ﹤0.01% 3168
2021
Q1 		$10.3M Buy
560,910
+32,705
+6% +$686K ﹤0.01% 3134
2020
Q4 		$9.94M Buy
528,205
+37,187
+8% +$802K ﹤0.01% 3000
2020
Q3 		$10.4M Buy
491,018
+1,236
+0.3% +$28.9K ﹤0.01% 2766
2020
Q2 		$14.1M Buy
489,782
+351,931
+255% +$10.6M ﹤0.01% 2592
2020
Q1 		$4.83M Sell
137,851
-13,555
-9% -$439K ﹤0.01% 2986
2019
Q4 		$3.7M Buy
+151,406
New +$2.66M ﹤0.01% 3271

Other funds holding OYST

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Vanguard Group's OYST Position: Q1 2023 in Review

Vanguard Group sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 13,500 shares — an estimated $151K sold.

Vanguard Group first reported a position in OYST in Q4 2019 and held it in 13 quarters. The position peaked at $14.1M in Q2 2020. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

  • Vanguard Group reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Vanguard Group sold 13,500 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $151K.
  • Vanguard Group first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 13 quarters.
  • Vanguard Group's Oyster Point Pharma, Inc. Common Stock position peaked at $14.1M in Q2 2020.
  • 1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Vanguard Group's 13F filing for Q1 2023, filed 15 May 2023.